{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:24:44Z","timestamp":1792103084706,"version":"4.4.0"},"reference-count":38,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T00:00:00Z","timestamp":1750464000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Taiwan National Science and Technology Council","award":["112-2313-B-005-037"],"award-info":[{"award-number":["112-2313-B-005-037"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>Background\/Objectives: Alternative therapies for urinary tract infections (UTIs) have been explored, but their efficacy remains inconsistent. With rising antibiotic resistance, this study aimed to evaluate simplified postbiotic formulations derived from heat-killed probiotics for long-term protection against primary and recurrent UTIs in a murine model. Methods: We compared a multi-strain (seven-strain) versus a single-strain postbiotic in preventing Escherichia coli-induced UTIs and recurrent polymicrobial UTIs, assessed protection persistence after treatment discontinuation, and established a novel sustained UTI model via intravesical co-inoculation of three uropathogens. Mice were allocated to three experimental groups: a placebo group (PBS), Postbiotic I group (a seven-strain heat-killed probiotic formulation), and Postbiotic II group (a single-strain heat-killed probiotic). After two weeks of treatment, mice were challenged with uropathogenic E. coli (UPEC) and treated for seven days. Following a 14-day washout and bacterial clearance, they were rechallenged with multidrug-resistant UPEC, Klebsiella pneumoniae, and Staphylococcus pseudintermedius. Results: Both postbiotics significantly accelerated bacterial clearance in primary UTIs (p &lt; 0.05). In recurrent UTIs, placebo-treated mice exhibited persistent bacteriuria, while Postbiotic I maintained a significantly higher sterile urine rate (50\u201380%, p &lt; 0.01) post-treatment. Histopathological analysis confirmed reduced bladder and kidney inflammation (p &lt; 0.05) with Postbiotic I. Conclusions: These findings demonstrate the superior efficacy of Postbiotic I in mitigating UTIs, with sustained protection post-treatment, supporting its potential as a long-term, non-antibiotic strategy. Additionally, our reproducible chronic UTI model, achieved through the co-inoculation of three uropathogens, provides a valuable tool for future research on chronic UTI pathogenesis and treatment.<\/jats:p>","DOI":"10.3390\/antibiotics14070634","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T09:08:44Z","timestamp":1750669724000},"page":"634","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Oral Administration of Heat-Killed Multi-Strain Probiotics Confers Durable Protection Against Antibiotic-Resistant Primary and Recurrent Urinary Tract Infections in a Murine Model"],"prefix":"10.3390","volume":"14","author":[{"given":"Bo-Yuan","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Veterinary Medicine, College of Veterinary Medicine, National Chung Hsing University, Taichung 40249, Taiwan"},{"name":"Department of Safety, Health and Environmental Engineering, Ming Chi University of Technology, New Taipei City 24301, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9480-4023","authenticated-orcid":false,"given":"Zhen-Shu","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Safety, Health and Environmental Engineering, Ming Chi University of Technology, New Taipei City 24301, Taiwan"},{"name":"Chronic Diseases and Health Promotion Research Center, Chang Gung University of Science and Technology, Chiayi 61363, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Syuan","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Veterinary Medicine, College of Veterinary Medicine, National Chung Hsing University, Taichung 40249, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiao Chin","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Veterinary Medicine, College of Veterinary Medicine, National Chung Hsing University, Taichung 40249, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1230-1532","authenticated-orcid":false,"given":"Po-Wen","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Veterinary Medicine, College of Veterinary Medicine, National Chung Hsing University, Taichung 40249, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,21]]},"reference":[{"key":"ref_1","first-page":"4238","article-title":"A systematic review of recent advances in urinary tract infection interventions and treatment technology","volume":"28","author":"Alam","year":"2024","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s12126-024-09569-6","article-title":"Global Prevalence of Urinary Tract Infections in the Older Persons: A Systematic Review and Meta-Analysis","volume":"49","author":"Kalhori","year":"2024","journal-title":"Ageing Int."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Mancuso, G., Midiri, A., Gerace, E., Marra, M., Zummo, S., and Biondo, C. (2023). Urinary Tract Infections: The Current Scenario and Future Prospects. Pathogens, 12.","DOI":"10.3390\/pathogens12040623"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1053\/j.ajkd.2023.08.009","article-title":"Urinary Tract Infections: Core Curriculum 2024","volume":"83","author":"Blair","year":"2024","journal-title":"Am. J. Kidney Dis."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Zhou, Y., Zhou, Z., Zheng, L., Gong, Z., Li, Y., Jin, Y., Huang, Y., and Chi, M. (2023). Urinary Tract Infections Caused by Uropathogenic Escherichia coli: Mechanisms of Infection and Treatment Options. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241310537"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"592","DOI":"10.4161\/viru.22364","article-title":"Molecular blueprint of uropathogenic Escherichia coli virulence provides clues toward the development of anti-virulence therapeutics","volume":"3","author":"Kostakioti","year":"2012","journal-title":"Virulence"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s11845-016-1538-z","article-title":"Antibiotic resistance patterns of Escherichia coli urinary isolates and comparison with antibiotic consumption data over 10 years, 2005\u20132014","volume":"186","author":"Stapleton","year":"2017","journal-title":"Ir. J. Med. Sci."},{"key":"ref_8","first-page":"CD001209","article-title":"Antibiotics for preventing recurrent urinary tract infection in non-pregnant women","volume":"2004","author":"Albert","year":"2004","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_9","first-page":"CD001534","article-title":"Long-term antibiotics for preventing recurrent urinary tract infection in children","volume":"2019","author":"Williams","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"104075","DOI":"10.1016\/j.pdpdt.2024.104075","article-title":"An update on alternative therapy for Escherichia coli causing urinary tract infections; a narrative review","volume":"46","author":"Nasrollahian","year":"2024","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s11884-022-00678-z","article-title":"Efficacy and safety of alternative treatments for the prevention of recurrent urinary tract infections","volume":"18","author":"Finney","year":"2023","journal-title":"Curr. Bladder Dysfunct. Rep."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1001\/jamainternmed.2024.0264","article-title":"d-Mannose for Prevention of Recurrent Urinary Tract Infection Among Women: A Randomized Clinical Trial","volume":"184","author":"Hayward","year":"2024","journal-title":"JAMA Intern. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"130","DOI":"10.24911\/BioMedica\/5-1183","article-title":"The role of probiotic in preventing recurrent urinary tract infections in pregnant women","volume":"40","author":"Kazi","year":"2024","journal-title":"Biomedica"},{"key":"ref_14","first-page":"CD008772","article-title":"Probiotics for preventing urinary tract infections in adults and children","volume":"2015","author":"Schwenger","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41390-020-01298-1","article-title":"Perspectives from the Society for Pediatric Research: Probiotic use in urinary tract infections, atopic dermatitis, and antibiotic-associated diarrhea: An overview","volume":"90","author":"Forster","year":"2021","journal-title":"Pediatr. Res."},{"key":"ref_16","first-page":"e7695","article-title":"Probiotics for prophylaxis and treatment of urinary tract infections in children","volume":"27","author":"Beyitler","year":"2017","journal-title":"Iran. J. Pediatr."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1001\/archinternmed.2012.777","article-title":"Lactobacilli vs antibiotics to prevent urinary tract infections: A randomized, double-blind, noninferiority trial in postmenopausal women","volume":"172","author":"Nys","year":"2012","journal-title":"Arch. Intern. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.58803\/RBES.2023.2.1.01","article-title":"The power of probiotics to combat urinary tract infections: A comprehensive review","volume":"2","author":"Qasemi","year":"2023","journal-title":"Res. Biotechnol. Environ. Sci."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Thorakkattu, P., Khanashyam, A.C., Shah, K., Babu, K.S., Mundanat, A.S., Deliephan, A., Deokar, G.S., Santivarangkna, C., and Nirmal, N.P. (2022). Postbiotics: Current Trends in Food and Pharmaceutical Industry. Foods, 11.","DOI":"10.3390\/foods11193094"},{"key":"ref_20","first-page":"2","article-title":"Therapeutic effects of orally administration of viable and inactivated probiotic strains against murine urinary tract infection","volume":"31","author":"Van","year":"2023","journal-title":"J. Food Drug Anal."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1056\/NEJM198208193070802","article-title":"Diagnosis of coliform infection in acutely dysuric women","volume":"307","author":"Stamm","year":"1982","journal-title":"N. Engl. J. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S0022-5347(02)80328-7","article-title":"Asymptomatic infections of the urinary tract","volume":"167","author":"Kass","year":"2002","journal-title":"J. Urol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Smelt, M.J., de Haan, B.J., Bron, P.A., van Swam, I., Meijerink, M., Wells, J.M., Kleerebezem, M., Faas, M.M., and de Vos, P. (2013). The impact of Lactobacillus plantarum WCFS1 teichoic acid D-alanylation on the generation of effector and regulatory T-cells in healthy mice. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0063099"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3920\/BM2020.0109","article-title":"Lacticaseibacillus paracasei NK112 mitigates Escherichia coli-induced depression and cognitive impairment in mice by regulating IL-6 expression and gut microbiota","volume":"12","author":"Yun","year":"2021","journal-title":"Benef. Microbes"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e00327-18","DOI":"10.1128\/IAI.00327-18","article-title":"Urine Cytokine and Chemokine Levels Predict Urinary Tract Infection Severity Independent of Uropathogen, Urine Bacterial Burden, Host Genetics, and Host Age","volume":"86","author":"Armbruster","year":"2018","journal-title":"Infect. Immun."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Chen, Y.-Y., Liu, Z.-S., Chen, B.-Y., Tam, H.-M.-H., Shia, W.-Y., Yu, H.-H., and Chen, P.-W. (2024). Effects of Heat-Killed Probiotic Strains on Biofilm Formation, Transcription of Virulence-Associated Genes, and Prevention of UTIs in Mice. Probiotics Antimicrob. Proteins, 1\u201316.","DOI":"10.1007\/s12602-024-10399-w"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Hishiki, H., Kawashima, T., Tsuji, N.M., Ikari, N., Takemura, R., Kido, H., and Shimojo, N. (2020). A double-blind, randomized, placebo-controlled trial of heat-killed Pediococcus acidilactici K15 for prevention of respiratory tract infections among preschool children. Nutrients, 12.","DOI":"10.3390\/nu12071989"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Takeshita, K., Hishiki, H., Takei, H., Ikari, N., Tanaka, S., Iijima, Y., Ogata, H., Fujishiro, K., Tominaga, T., and Konno, Y. (2024). The Effectiveness of Heat-Killed Pediococcus acidilactici K15 in Preventing Respiratory Tract Infections in Preterm Infants: A Pilot Double-Blind, Randomized, Placebo-Controlled Study. Nutrients, 16.","DOI":"10.3390\/nu16213635"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Pique, N., Berlanga, M., and Minana-Galbis, D. (2019). Health Benefits of Heat-Killed (Tyndallized) Probiotics: An Overview. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20102534"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"164","DOI":"10.4161\/gmic.1.3.12127","article-title":"Safety assessment of probiotics for human use","volume":"1","author":"Sanders","year":"2010","journal-title":"Gut Microbes"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41575-021-00440-6","article-title":"The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics","volume":"18","author":"Salminen","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ijantimicag.2014.01.016","article-title":"Colistin-based treatment for extensively drug-resistant Acinetobacter baumannii pneumonia","volume":"43","author":"Khawcharoenporn","year":"2014","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1128\/IAI.66.6.2798-2802.1998","article-title":"Time course and host responses to Escherichia coli urinary tract infection in genetically distinct mouse strains","volume":"66","author":"Hopkins","year":"1998","journal-title":"Infect. Immun."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1086\/511866","article-title":"Adherence to the Infectious Diseases Society of America guidelines in the treatment of uncomplicated urinary tract infection","volume":"44","author":"Taur","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1128\/AAC.02101-13","article-title":"Role of OmpA in the multidrug resistance phenotype of Acinetobacter baumannii","volume":"58","author":"Smani","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.molimm.2019.02.007","article-title":"Urinary tract infection: Pathogenicity, antibiotic resistance and development of effective vaccines against Uropathogenic Escherichia coli","volume":"108","author":"Karam","year":"2019","journal-title":"Mol. Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1128\/AAC.45.6.1751-1760.2001","article-title":"Antimicrobial activity of intraurethrally administered probiotic Lactobacillus casei in a murine model of Escherichia coli urinary tract infection","volume":"45","author":"Asahara","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1111\/j.1572-0241.1999.01377.x","article-title":"Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions","volume":"94","author":"Brunt","year":"1999","journal-title":"Am. J. Gastroenterol."}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/14\/7\/634\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:56:15Z","timestamp":1760032575000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/14\/7\/634"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,21]]},"references-count":38,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["antibiotics14070634"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics14070634","relation":{},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,21]]}}}